nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AI in drug discovery: A wake-up call
|
Urbina, Fabio |
|
|
28 |
1 |
p. |
artikel |
2 |
Benefits of hybrid QM/MM over traditional classical mechanics in pharmaceutical systems
|
Kar, Rajiv K. |
|
|
28 |
1 |
p. |
artikel |
3 |
Chiral-engineered supraparticles: Emerging tools for drug delivery
|
Rahman, Mahfoozur |
|
|
28 |
1 |
p. |
artikel |
4 |
Contents page
|
|
|
|
28 |
1 |
p. |
artikel |
5 |
CRISPR/Cas9 in the era of nanomedicine and synthetic biology
|
Schmidt, Tiziana Julia Nadjeschda |
|
|
28 |
1 |
p. |
artikel |
6 |
Development of the PC-NSAID technology: From contact angle to Vazalore®
|
Lichtenberger, Lenard M. |
|
|
28 |
1 |
p. |
artikel |
7 |
Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs)
|
Saraswat, Aishwarya L. |
|
|
28 |
1 |
p. |
artikel |
8 |
Drug repurposing using real-world data
|
Tan, George S.Q. |
|
|
28 |
1 |
p. |
artikel |
9 |
Engineered nanomedicines to overcome resistance of pancreatic cancer to immunotherapy
|
Elzoghby, Ahmed O. |
|
|
28 |
1 |
p. |
artikel |
10 |
Mass spectrometry in gene therapy: Challenges and opportunities for AAV analysis
|
Serrano, Mahalia A.C. |
|
|
28 |
1 |
p. |
artikel |
11 |
Metal, metal oxide and polymeric nanoformulations for the inhibition of bacterial quorum sensing
|
Alavi, Mehran |
|
|
28 |
1 |
p. |
artikel |
12 |
Monoclonal antibodies: Trends in therapeutic success and commercial focus
|
Kinch, Michael S. |
|
|
28 |
1 |
p. |
artikel |
13 |
Optical tweezers for drug discovery
|
Halma, Matthew T.J. |
|
|
28 |
1 |
p. |
artikel |
14 |
pH and its applications in targeted drug delivery
|
Abdella, Sadikalmahdi |
|
|
28 |
1 |
p. |
artikel |
15 |
Pharmacological treatment strategies of pterygium: Drugs, biologics, and novel natural products
|
Baheran, Sanaz Sadig |
|
|
28 |
1 |
p. |
artikel |
16 |
Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes
|
Pang, Huiwen |
|
|
28 |
1 |
p. |
artikel |
17 |
PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery
|
Guedeney, Nicolas |
|
|
28 |
1 |
p. |
artikel |
18 |
PROTACting the kinome with covalent warheads
|
Chatterjee, Deep Rohan |
|
|
28 |
1 |
p. |
artikel |
19 |
Recent advances in flavonoid-based nanocarriers as an emerging drug delivery approach for cancer chemotherapy
|
Dewanjee, Saikat |
|
|
28 |
1 |
p. |
artikel |
20 |
Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: A survey of their current use and future outlook
|
Callenbach, Marcelien H.E. |
|
|
28 |
1 |
p. |
artikel |
21 |
Senotherapeutics for mesenchymal stem cell senescence and rejuvenation
|
Wong, Pooi-Fong |
|
|
28 |
1 |
p. |
artikel |
22 |
Targeting strategies for modulating pre-mRNA splicing with small molecules: Recent advances
|
Barraza, Scott J. |
|
|
28 |
1 |
p. |
artikel |
23 |
The clinical significance of 4D printing
|
Sheikh, Afsana |
|
|
28 |
1 |
p. |
artikel |
24 |
Therapeutic potential of fucosyltransferases in cancer and recent development of targeted inhibitors
|
Lv, Yixin |
|
|
28 |
1 |
p. |
artikel |
25 |
The transmembrane domains of GPCR dimers as targets for drug development
|
Cai, Xin |
|
|
28 |
1 |
p. |
artikel |